Medicine and Dentistry
Adrenal Cortex Carcinoma
63%
Adrenalectomy
31%
Biopsy
18%
Bladder Cancer
39%
Bladder Tumor
31%
Cavernosography
19%
Chronic Kidney Disease
14%
Clear Cell Renal Cell Carcinoma
63%
Clinical Management
10%
Cystectomy
63%
Disease
34%
Hematuria
15%
Kaplan Meier Method
13%
Kidney Function
84%
Kidney Injury
23%
Kidney Tumour
41%
Logistic Regression Analysis
13%
Lymph Node
31%
Magnetic Resonance Imaging
31%
Malignant Neoplasm
55%
Metastatic Carcinoma
36%
Methoxy Isobutyl Isonitrile Technetium Tc 99m
31%
Micropapillary
31%
microRNA
31%
Multivariate Analysis
22%
Neoplasm
92%
Nephrectomy
31%
Odds Ratio
15%
Oncocytoma
47%
Overactive Bladder
31%
Overall Survival
100%
Partial Nephrectomy
94%
Patient Counseling
10%
Peyronie's Disease
31%
Proportional Hazards Model
23%
Radiation Therapy
36%
Radical Nephrectomy
31%
Single Photon Emission Computed Tomography-Computed Tomography
31%
Surgeon
11%
Surgery
31%
Surgical Approach
31%
Surgical Margin
16%
Symptom
31%
Symptom Assessment
31%
Technetium-99
31%
Transitional Cell Carcinoma
47%
Transurethral Resection
31%
Univariate Analysis
22%
Urethroplasty
31%
Urodynamics
31%
Keyphrases
Adjuvant Therapy
6%
Adrenal Lesions
6%
Adrenocortical Carcinoma
31%
Anterior Urethroplasty
6%
Cavernosography
19%
Chromophobe
7%
Clinical T Stage
31%
Cold Mass
7%
Delayed Intervention
15%
Discharge Day
13%
Disease-specific Questionnaire
6%
Ecological Momentary
31%
Enlarged Prostate
31%
EQ-5D-3L
6%
Fusion Biopsy
6%
Holmium Laser Enucleation of the Prostate (HoLEP)
31%
International Index of Erectile Function
12%
Length of Stay
6%
Low-risk Prostate Cancer
18%
Men's Sexual Health
6%
Message-based
6%
Micropapillary Component
31%
Minimally Invasive Adrenalectomy
58%
Momentary Symptom Assessment
31%
National Cancer Database
6%
Nodal Yield
31%
Oncocytic Tumors
31%
Oncologic
31%
Open Adrenalectomy
22%
Overactive Bladder Symptom Score (OABSS)
31%
Overall Survival
6%
Parenchymal Analysis
31%
Perioperative Morbidity
31%
Peyronie's Disease
31%
Post-void Residual
6%
Postneoadjuvant Therapy
15%
Postoperative Depression
18%
Prostate-specific Antigen Nadir
12%
Reconstructive Urology
6%
Sacral Nerve Stimulator
31%
Semi-automated Software
6%
Stricture Recurrence
6%
Surgical Approach
31%
Symptom Recovery
31%
Treatment Burden
31%
Trimix
7%
Urethral Stricture Disease
25%
Urethroplasty
31%
Urethrorrhagia
7%
Will Rogers Phenomenon
31%